New cancer treatment to improve patient outcomes

Chinese scientists have developed a new treatment for nasopharyngeal carcinoma that helps patients live longer and have a better quality of life compared with traditional therapies that often cause severe side effects.

Nasopharyngeal carcinoma is a type of cancer that originates in the nasopharynx, which is the upper part of the throat behind the nose.

Ma Jun, an academician of the Chinese Academy of Sciences, said Chinese oncologists have taken the lead in establishing a new immunotherapy-based regimen combined with chemoradiotherapy, eliminating the need for concurrent cisplatin in treating locally advanced nasopharyngeal carcinoma. The new approach has shown improved treatment outcomes for patients.